Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Tito Livraghi"'
The book is edited by a multidisciplinary team, with an international group of contributors. After discussing the basic and clinical aspects of HCC the main focus of the book is on diagnosis and therapy. The book is both authoritative and practical,
Autor:
Tito Livraghi
Publikováno v:
World Futures. 72:205-217
Hepatocellular carcinoma (HCC) represents the third leading cause of cancer-related death. Because HCC is multicentric with time, excluding the few transplanted patients, sooner or later it becomes untreatable with loco-regional therapies and, until
Publikováno v:
Hepatocellular Carcinoma ISBN: 9783319342122
Hepatocellular Carcinoma ISBN: 9781603273732
Hepatocellular Carcinoma ISBN: 9781603273732
The chapter considers the principles, the techniques, the results of PEI for treating cirrhotic patients with HCC, and its current indications compared to those of RF, which is now considered the gold standard.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6203429103a8a65294a2f3573c44efd
https://doi.org/10.1007/978-3-319-34214-6_29
https://doi.org/10.1007/978-3-319-34214-6_29
Publikováno v:
Liver Transplantation. 17:S117-S127
Norman Kneteman, Tito Livraghi, David Madoff, Eduardo de Santibanez, and Michael Kew Division of Transplantation, Department of Surgery, University of Alberta, Edmonton, Alberta, Canada; Department of Interventional Radiology, Istituto Clinico Humani
Autor:
M G Pich, Guido Torzilli, M. A. Tommasini, Angela Palmisano, Vittorio Pedicini, R. Ceriani, Tito Livraghi
Publikováno v:
Current Pharmaceutical Biotechnology. 12:254-260
Hepatocellular carcinoma (HCC) represents the third cause of cancer-related death. Because HCC is multi-centric with time, excluding the few transplanted patients, sooner or later it becomes untreatable with loco-regional therapies and, until some ye
Publikováno v:
Journal of Surgical Oncology. 102:868-876
Purpose: Recommendations of the Barcelona Clinic Liver Cancer (BCLC) therapeutic flow-chart, endorsed by the American Association for the Study of Liver Diseases (AASLD), are the most applied worldwide. Over recent years, however, several referral ce
Autor:
Fred T. Lee, Anita Andreano, Paul F. Laeseke, Maria Franca Meloni, Tito Livraghi, Sandro Sironi
Publikováno v:
Radiology. 253:861-869
PURPOSE: To retrospectively assess the local control and intermediate- and long-term survival of patients with liver metastases from breast cancer who have undergone percutaneous ultrasonography (US)-guided radiofrequency (RF) ablation. MATERIALS AND
Autor:
Tito Livraghi
Publikováno v:
Journal of Hepato-Biliary-Pancreatic Sciences. 17:425-429
In the EASL and AASLD guidelines, hepatic resection (HR) is considered the first option for patients in stage 0 (very early HCC). This statement was not based on randomized controlled trials (RCTs) versus other therapies, but on the oncological assum
Autor:
Pallavicini D, S N Goldberg, Maria Franca Meloni, Campani R, Paolo Ricci, Fabrizio Calliada, Tito Livraghi, Michele Rossi
Publikováno v:
Scopus-Elsevier
The purpose of this study was to compare the efficacy of contrast-enhanced pulse inversion harmonic imaging with contrast-enhanced power Doppler sonography and helical CT to determine incomplete local treatment after radiofrequency ablation in patien
Autor:
Tito Livraghi
Publikováno v:
European Journal of Ultrasound. 13:167-176
In the treatment of hepatocellular carcinoma, the range of indications for percutaneous ablation techniques is becoming wider than surgery and intra-arterial therapies. Indeed, whereas for some years only patients with up to three small lesions were